FDA Faces Pressure to Approve Non-Opioid Pain Drugs
System barriers slow progress toward safer, effective non-opioid pain treatments.
System barriers slow progress toward safer, effective non-opioid pain treatments.
Appeals court orders renewed trial against distributors in the state.
Authorities seized nitazene in Nassau County, marking first Northeast discovery.
Providing treatment for opioid addiction in jails lowers overdose risk and improves post-release recovery.
Study reveals thousands of uncounted opioid deaths, raising concerns about treatment funding.
The state distributes millions to support local opioid treatment and prevention programs.
Emergency visits for low back pain see fewer opioids but steady imaging.
Maryland city debates accepting reduced opioid settlement or pursuing risky new trial.
FDA updates opioid labels to highlight overdose risks and long-term dangers.
Blocking opioid receptors reduced ketamine’s brain activity and mood benefits.